|
|
40
|
|
|
B4214
|
|
|
JARDIANCE 25MG TAB (BOE/STO) EMPAGLIFLOZIN
|
|
|
EMPAGLIFLOZIN
|
|
|
JARDIANCE
|
|
|
30'S
|
|
|
A
|
|
|
67.25
|
|
|
2.24
|
|
|
25MG
|
|
|
TABLET
|
|
|
30
|
|
|
TAB
|
|
|
BOE
|
|
|
BOEHRINGER INGELHEIM
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
682018
|
|
|
SODIUM-GLUCOSE COTRANSPORTER INHIBITOR
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|